BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2128203)

  • 1. [Presence of antibodies to lectin CSL in the blood of patients with multiple sclerosis patients].
    Zanetta JP; Warter JM; Lehmann S; Tranchant C; Kuchler S; Vincendon G
    C R Acad Sci III; 1990; 311(9):327-31. PubMed ID: 2128203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is Cerebellar Soluble Lectin a major immunological target in multiple sclerosis?].
    Zanetta JP; Warter JM; Lehmann S; Kuchler S; Vincendon G
    Pathol Biol (Paris); 1991 Jan; 39(1):7-11. PubMed ID: 2011413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of anti-CSL antibodies in the cerebrospinal fluid of patients: a sensitive and specific test in the diagnosis of multiple sclerosis.
    Zanetta JP; Tranchant C; Kuchler-Bopp S; Lehmann S; Warter JM
    J Neuroimmunol; 1994 Jul; 52(2):175-82. PubMed ID: 8034757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to cerebellar soluble lectin CSL in multiple sclerosis.
    Zanetta JP; Warter JM; Kuchler S; Marschal P; Rumbach L; Lehmann S; Tranchant C; Reeber A; Vincendon G
    Lancet; 1990 Jun; 335(8704):1482-4. PubMed ID: 1972431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis patients.
    Warren KG; Catz I
    Ann Neurol; 1987 Feb; 21(2):183-9. PubMed ID: 2435224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-heat shock protein 90beta antibodies are detected in patients with multiple sclerosis during remission.
    Cid C; Regidor I; Alcázar A
    J Neuroimmunol; 2007 Mar; 184(1-2):223-6. PubMed ID: 17161872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the detection of the anti-measles antibodies in the spinal fluid of patients with multiple sclerosis].
    Dioli GL; Mazzoni S; Ferrucci M
    Riv Neurobiol; 1969; 15(1):63-71. PubMed ID: 5399616
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies to cerebellar soluble lectin in multiple sclerosis.
    Hughes RA
    Lancet; 1990 Aug; 336(8712):438-9. PubMed ID: 1974963
    [No Abstract]   [Full Text] [Related]  

  • 9. Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes.
    Jolivet-Reynaud C; Perron H; Ferrante P; Becquart L; Dalbon P; Mandrand B
    Clin Immunol; 1999 Dec; 93(3):283-93. PubMed ID: 10600340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid anti-cerebellar soluble lectin antibodies in human immunodeficiency virus type 1 infection.
    Hagberg L; Norkrans G; Zanetta JP; Lehmann S; Bergström T
    J Neuroimmunol; 1992 Feb; 36(2-3):245-9. PubMed ID: 1732284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid and peripheral blood lymphocyte subpopulations in multiple sclerosis. Evaluation by means of monoclonal antibodies (a preliminary note).
    Biglino A; Baggio GF; Gioannini P; Mombelli A
    Boll Ist Sieroter Milan; 1982; 61(5):432-6. PubMed ID: 6242102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paramyxovirus SV5 and multiple sclerosis.
    Vandvik B; Norrby E
    Nature; 1989 Apr; 338(6218):769-71. PubMed ID: 2541340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of cerebrospinal fluid anti-myelin basic protein in patients with multiple sclerosis.
    Warren KG; Catz I
    Ann Neurol; 1986 Jul; 20(1):20-5. PubMed ID: 2427010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant cells have increased levels of common glycoprotein ligands of the endogenous cerebellar soluble lectin CSL.
    Maschke S; Robert J; Coindre JM; Kuchler S; Vincendon G; Zanetta JP
    Eur J Cell Biol; 1993 Oct; 62(1):163-72. PubMed ID: 8269974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intrathecal secretion of antiviral antibodies in multiple sclerosis in patients in Seville].
    Izquierdo G; Druetta E; Navarro G; Galán A; Borobio MV; Angulo S; Quesada MA; Martínez-Parra C
    Neurologia; 1990 May; 5(5):151-4. PubMed ID: 2169273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid.
    Chofflon M; Weiner HL; Morimoto C; Hafler DA
    Ann Neurol; 1989 May; 25(5):494-9. PubMed ID: 2528316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of determination of antibodies to myelin basic protein in the cerebrospinal fluid].
    Dong WW
    Zhonghua Yi Xue Za Zhi; 1987 Feb; 67(2):82-5. PubMed ID: 2439180
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies against the paramyxovirus SV5 in the cerebrospinal fluids of some multiple sclerosis patients.
    Goswami KK; Randall RE; Lange LS; Russell WC
    Nature; 1987 May 21-27; 327(6119):244-7. PubMed ID: 3553964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis.
    Sumaya CV; Myers LW; Ellison GW; Ench Y
    Ann Neurol; 1985 Apr; 17(4):371-7. PubMed ID: 2988410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE.
    Endo T; Scott DD; Stewart SS; Kundu SK; Marcus DM
    J Immunol; 1984 Apr; 132(4):1793-7. PubMed ID: 6699401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.